Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...
The Rajiv Gandhi Centre for Biotechnology becomes a national Next-Generation Sequencing hub, aiming to combat acute febrile illnesses through advanced metagenomic surveillance. A collaborative project ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...
The ongoing Italian clinical and research FPG500 program is designed to tailor matched targeted therapies (MTTs) based on "biomarkers predictive of response identified by comprehensive genome profiling ...
Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...
A central challenge in relapsed/refractory follicular lymphoma is determining a treatment sequence that maximizes current ...
Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale data generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback